New solution integrates evidence-based digital care programs with best-in-class mental health provider networkSAN FRANCISCO, March 21, 2024 /PRNewswire/ -- Big Health , the leading developer of digital treatments for the most common mental health conditions, has partnered with Grow Therapy ("Grow") to launch a comprehensive mental health platform that will support the full spectrum of mental health care needs. Grow's best-in-class provider network will seamlessly integrate with Big Health's clinically proven digital programs for insomnia, anxiety, and depression. The experience will be integrated into customers' existing benefit ecosystems, and offer care to millions for a fraction of the cost of existing platforms.Despite double-digit growth in investments in this area, the mental health crisis continues to worsen. The collaboration between Big Health and Grow Therapy will provide flexibility and scalability in addressing the exploding demand for mental health care services."Mental health continues to be a top priority for employers and other traditional benefits customers. They are facing enormous financial pressure with rising medical spend and economic headwinds. We are meeting the need for a solution that combines the best clinical care and digital programs in one platform that can be billed up to 100% through claims, with no benefits budget required," said Arun Gupta, Big Health's Executive Chairman & CEO.The new comprehensive mental health platform is built for the challenging market dynamics facing organizations, including utilization-based pricing, claims-based billing, and performance guarantees tied to clinical results

"These new data show how treating sleep issues has health benefits across populations, conditions, and ages—rest helps heal our bodies and brains, and is essential to a healthy mind," Colin A. Espie, PhD, Prof. of Sleep Medicine, University of Oxford; co-founder, Chief Scientific Officer, Big Health Tweet thisEighty-four percent of improvements in anxiety among study participants using Sleepio were due to improvements in sleep.In a separate study among stroke survivors, 71% achieved remission using Sleepio compared to 30% of control participants.Improving sleep is a pathway to reduce anxietyIndividuals with insomnia are three times more likely to develop anxiety than healthy sleepers.[1] Additionally, comorbid insomnia and anxiety are associated with greater severity of both conditions — as well as increased symptoms of depression and poorer physical health.[2]Published in the peer-reviewed Journal of Affective Disorders, researchers found that Sleepio's clinically validated impact on insomnia also significantly reduced participants' anxiety symptoms — 84% of improvements in anxiety were due to improvements in sleep. The largest-ever study examining the effects of a digital therapeutic for insomnia in adults with insomnia and clinically significant anxiety, results also showed that after using Sleepio, participants were two times more likely to no longer have clinically significant anxiety versus those in the control arm."The results of our studies show that digital CBT for insomnia can bring about substantial improvements in sleep, and that leads to a lessening of anxiety and depression," Daniel Freeman, PhD, Professor of Psychology at the University of Oxford and co-author of the paper, said. "Improving sleep likely brings a wide range of benefits in its wake."The impact of sleep on stroke recoveryGlobally, one in four people are estimated to experience stroke during their lifetime, and the disease is the third leading cause of disability and death combined.[3] Following stroke, up to 60% of patients report sleep challenges throughout the recovery period.[3] Sleep issues are associated with poorer post-stroke outcomes[4] and higher rates of comorbidity, including anxiety and depression.[5]The peer-reviewed Journal of Sleep Research published results from the INSPIRES study, a randomized controlled trial (RCT) comprising 84 stroke survivors demonstrating that Sleepio was effective at improving sleep, compared with sleep hygiene control, for at least eight weeks post-intervention. Results also showed that, among participants who had insomnia disorder at baseline, 71% in the Sleepio study arm achieved remission post-intervention compared to 30% of control participants